SANFER Col
The status, timeline and source of this project. A free account opens every field.
Source: International Finance Corporation (IFC)
Founded in 1941, Laboratorios Sanfer (“Sanfer”) is the second largest domestic pharmaceutical company in Mexico and amongst the top 8 largest in Latin America. Laboratorios Bussie, S.A. (“Bussie”) and Laboratorio International de Colombia, S.A.S. (“Labinco”) are fully owned subsidiaries of Sanfer and were acquired in 2008 and 2015, respectively. Bussie and Labinco (hereafter referred to as “Sanfe
- Status
- Closed
- Sector
- Manufacturing (Industrial), Government
- Location
- Colombia
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about SANFER Col
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | hold |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Founded in 1941, Laboratorios Sanfer (“Sanfer”) is the second largest domestic pharmaceutical company in Mexico and amongst the top 8 largest in Latin America. Laboratorios Bussie, S.A. (“Bussie”) and Laboratorio International de Colombia, S.A.S. (“Labinco”) are fully owned subsidiaries of Sanfer and were acquired in 2008 and 2015, respectively. Bussie and Labinco (hereafter referred to as “Sanfer Colombia”) commercialize a wide portfolio of prescription and over-the-counter (OTC) drugs (e.g. pulmonology, ophthalmology, gastrointestinal, cardiovascular, psychoactive, antiparasitic, antibiotics, and veterinary drugs). With exception of veterinary drugs which are produced by three third-party contract manufacturers, the majority of drugs are produced in Bussie’s and Labinco’s manufacturing plants located in Bogota, Colombia. IFC propose financing a $11.5 million for the construction of a new manufacturing plant for finished dosage forms, which will replace the existing operations, to satisfy the new and more stringent regulatory requirements from the National Institute for Drugs and Food Surveillance (INVIMA). The new plant will be located in an industrial area in the city of Bogota, a few blocks from the existing plants https://goo.gl/maps/jDJQN6VqzQBxejQ49. Administrative offices and the quality control laboratory will remain in separate existing locations. |
Original sector | other |
Location
Country | Colombia |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Government |
Article published date | 2025-08-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
